Correlation Between Catalyst Pharmaceuticals and Mid-Atlantic Home

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Mid-Atlantic Home at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Mid-Atlantic Home into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Mid Atlantic Home Health, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Mid-Atlantic Home and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Mid-Atlantic Home. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Mid-Atlantic Home.

Diversification Opportunities for Catalyst Pharmaceuticals and Mid-Atlantic Home

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Catalyst and Mid-Atlantic is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Mid Atlantic Home Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mid Atlantic Home and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Mid-Atlantic Home. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mid Atlantic Home has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Mid-Atlantic Home go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Mid-Atlantic Home

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.25 times more return on investment than Mid-Atlantic Home. However, Catalyst Pharmaceuticals is 1.25 times more volatile than Mid Atlantic Home Health. It trades about 0.05 of its potential returns per unit of risk. Mid Atlantic Home Health is currently generating about -0.05 per unit of risk. If you would invest  1,434  in Catalyst Pharmaceuticals on December 4, 2024 and sell it today you would earn a total of  855.00  from holding Catalyst Pharmaceuticals or generate 59.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Mid Atlantic Home Health

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Mid Atlantic Home 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mid Atlantic Home Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical indicators, Mid-Atlantic Home is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Catalyst Pharmaceuticals and Mid-Atlantic Home Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Mid-Atlantic Home

The main advantage of trading using opposite Catalyst Pharmaceuticals and Mid-Atlantic Home positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Mid-Atlantic Home can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mid-Atlantic Home will offset losses from the drop in Mid-Atlantic Home's long position.
The idea behind Catalyst Pharmaceuticals and Mid Atlantic Home Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account